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Purpose: To screen the visual system homeobox 1 (VSX1) gene in keratoconus patients.
Methods: The enntire coding region of VSX1, including intron-exon boundaries were amplified in keratoconus cases
(n=50) and controls (n=50). All sequences were analyzed against the ensemble sequence (ENSG00000100987) for
VXS1.
Results: Sequencing analysis showed four alterations (p.A182A, p.R217H, p.P237P, and g.25059612C>T) in VSX1 of
which g.25059612C>T (in intron 2) was found to be novel. Of these four, p.A182A and p.P237P were present in both
cases as well as controls while p.R217H and g.25059612C>T were limited to cases only. All these changes were non-
pathogenic.
Conclusions: In our study no pathogenic VSX1 mutation was identified. The role of VSX1 in the pathogenesis of
keratoconus is still controversial. VSX1 mutations are responsible for a very small fraction of all observed keratoconus
cases. The absence of pathogenic mutations in VSX1 in our patients indicates that other genetic loci like 13q32 as suggested
by a recent study may be involved in the pathogenesis of this disorder.
Keratoconus (KTCN; OMIM 148300) is a bilateral, non-
inflammatory, and progredient corneal ectasia [1]. There is no
specific  treatment  for  keratoconus  except  corneal
transplantation. It has an estimated incidence between 1/500
to 1/2,000 persons throughout the world. The disease usually
arises in the teens and stabilizes in the third and fourth decade
of life [2]. It occurs with no ethnic or gender preponderance
and  causes  significant  visual  impairment.  Most  cases  of
keratoconus are sporadic but some (5%–10%) have a positive
family history [2,3]. In such cases both autosomal dominant
and recessive patterns of inheritance have been documented
[4-6]. The exact pathogenesis of keratoconus is still unknown.
Genome-wide  linkage  analyses  has  identified  several
chromosomal loci and genes that may be associated with
keratoconus [6-9]; however, some were eventually excluded
[10,11] while for others a conclusive association with the
disease is yet to be established. Mutations in the visual system
homeobox 1 (VSX1) gene in keratoconus have been reported
in different studies [12-15].
VSX1 is a member of the Vsx1 group of vertebrate paired-
like homeodomain transcription factors. It has been localized
to human chromosome 20p11-q11. Initially VSX1 was chosen
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for screening mutations in posterior polymorphous corneal
dystrophy (PPCD) and keratoconus [8]. VSX1 is considered
important in ocular development and is particularly involved
in  the  developing  cornea.  Expression  in  human  was
demonstrated in embryonic craniofacial, adult corneal, and
adult  retinal  cDNA  libraries  [16].  VSX1  mRNA  has  been
found in the outer tier of the inner nuclear layer of the human
retina and the cornea [17]. Mutations in this gene are also
associated with posterior polymorphous dystrophy. VSX1 is
highly  conserved  across  many  species  [18-20].  Several
mutations, such as p.D144E, p.G160D, p.P247R, p.L159M,
p.R166W, and p.H244R have been reported by various groups
[14,17,21] but a definite pathogenic role of these mutations in
keratoconus is not yet established. In this study we present the
results of VSX1 gene analysis in 50 keratoconus patients and
controls from north India.
METHODS
Patient selection and DNA isolation: The research followed
the tenets of the Declaration of Helsinki in the treatment of
the  subject  reported  herein.  The  study  was  approved  by
institutional review board (IRB # IRB00006862) of the All
India  Institute  of  Medical  Sciences  (AIIMS)  and  all
participants gave their written informed consent. A total of
fifty keratoconus patients (Table 1) presented (during April
2009 to April 2010) at the Dr. R. P. Centre for Ophthalmic
Sciences (AIIMS, New Delhi, India) were enrolled in this
study. Clinical evaluation involved Ultrasonic Pachymetry,
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2396videokeratography  (VKG),  Orbscan,  visual  testing,
fundoscopy,  slitlamp-biomicroscopy,  and  retinoscopy.  Of
these patients, 29 were males and 21 were females. The mean
age of presentation was 18.2 years. Diagnosis of keratoconus
involved the presence of characteristic topographic features,
such  as  inferior  or  central  corneal  steepening,  or  an
asymmetric bowtie pattern with skewing of the radial axes,
and the presence of one or more of the following characteristic
clinical  features  in  one  or  both  eyes:  conical  corneal
deformation,  munsen  sign,  corneal  stromal  thinning,  a
Fleischer ring or Vogt striae. All cases were sporadic without
any family history.
All keratoconus cases secondary to causes like trauma,
surgery, Ehlers Danlos syndrome, Osteogenesis Imperfecta,
and pellucid marginal degeneration were excluded from the
study.
After informed consent, detailed personal, medical and
occupational history was collected and a family tree up to
three generations was drawn. Fifty ethnically matched normal
individuals  without  any  ocular  disorder  were  enrolled  as
controls.  Health  information  was  obtained  from  controls
through the questionnaire; all underwent ophthalmological
examination and blood sample (5 ml) was collected in EDTA
(EDTA)  vacutainers  (Greiner  Bio-One  GmbH,
Frickenhausen, Germany) from patients and controls for DNA
extraction. DNA was extracted from whole blood samples of
all patients and controls using the phenol-chloroform method.
PCR and DNA sequencing: All the coding regions of VSX1
including exon-intron junctions were amplified using a set of
five oligonucleotide primers (Table 2). Each reaction was
performed in a 25 µl mixture containing 0.2 µM each primer,
0.5 U Taq DNA polymerase (Biogene, New Delhi, India),
2.5 µl 10× PCR buffer (Biogene) with 2.5 mM MgCl2, and
approximately 100 ng genomic DNA. Thermal cycling was
performed in a thermal cycler (My Cycler; Biorad, Gurgaon,
India) under the following conditions: initial denaturation for
3 min at 95 °C; 35 cycles of 94 °C for 30 s, 55 0-60 °C for 45
s, 72 °C for 60 s; and a final extension for 10 min at 72 °C.
All PCR products were analyzed on 1.8% agarose gel
stained with ethidium-bromide (EtBr; 10 mg/ml). Agarose
gels were analyzed using gel documentation system (Applied
Biosystems, Carlsbad, CA). Amplified PCR products were
purified  using  gel/PCR  DNA  fragments  extraction  kit
(DF100;  Geneaid  Biotech  Ltd.,  Sijhih  City  Taiwan).  The
purified PCR products were sent for sequencing at MCLAB
(Molecular Cloning Laboratories, South San Francisco, CA)
Nucleotide  sequences  were  compared  with  the  VSX1
ensembl reference sequence.
Insilico analysis of missense mutations: Two homology based
programs PolyPhen (Polymorphism Phenotyping) and SIFT
(Sorting Intolerant From Tolerant) analysis tool were used to
predict the functional impact of missense changes identified
in this study.
PolyPhen  structurally  analyzes  an  amino  acid
polymorphism and predicts whether that amino acid change
is likely to be deleterious to protein function [22,23]. The
prediction  is  based  on  the  position-specific  independent
counts  (PSIC)  score  derived  from  multiple  sequence
alignments of observations. PolyPhen scores of >2.0 indicate
the polymorphism is probably damaging to protein function.
Scores of 1.5–2.0 are possibly damaging, and scores of <1.5
are likely benign.
SIFT  is  a  sequence  homology-based  tool  that  sorts
intolerant from tolerant amino acid substitutions and predicts
whether an amino acid substitution in a protein will have a
phenotypic effect [24,25]. SIFT is based on the premise that
protein evolution is correlated with protein function. Positions
TABLE 2. PRIMERS USED FOR VSX1 GENE AMPLIFICATION.
Exon Forward primer (5′-3′) Reverse primer (5′-3′) Product size (bp)
1 CAGCTGATTGGAGCCCTTC CTCAGAGCCTAGGGGACAGG 599
2 GCACTAAAAATGCTGGCTCA GCCTCCTAGGAACTGCAGAA 393
3 CATTCAGAGGTGGGGTGTT TCTTGTGGTGCCTTCAGCTA 419
4 GATCATGCTCGGGAGAGAAG CGTTGCTTTGCTTTGGAAAT 394
5 CCCCAGAGATAGGCACTGAC TGGACAATTTTTGTCTTTTGG 495
TABLE 3. VSX1 SEQUENCE VARIANTS OBSERVED IN THIS STUDY.
Nucleotide Change VSX1 transcript ID Protein
alteration
Exon/
UTR/
intron
Patients
(n=50)
Controls
(n=50)
Reference/
SNP ID
Polyphen/SIFT
prediction
g.25059546A>G
(rs12480307)
NM_014588 p.A182A Exon 3 25/50 29/50 [20] –
g.25059442G>A
(rs6138482)
NM_0199425 p.R217H Exon 3 1/50 Absent [20] Non-pathogenic
g.25059381T>A
(rs56157240)
NM_0199425 p.P237P Exon 3 18/50 14/50 [20] –
g.25059612C>T – – Intron 2 3/50 Absent Novel –
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2397important for function should be conserved in an alignment
of the protein family, whereas unimportant positions should
appear diverse in an alignment. Positions with normalized
probabilities less than 0.05 are predicted to be deleterious and,
those greater than or equal to 0.05 are predicted to be tolerated.
We have also used improved Splice Site predictor tool
[26] for prediction the effect of an intronic nucleotide change
on splicing.
RESULTS
DNA  sequencing  analysis  of  50  patients  and  50  controls
revealed a total of four nucleotide changes (Table 3) of which
Figure 1. DNA sequence chromatogram of VSX1 equivalent to codon
181 to 184. A: The reference sequence derived from control is shown.
B: Sequence derived from keratoconus patient shows homozygous
A>G nucleotide change which predicts a codon change GCA>GCG
and synonymous change p.A182A.
Figure 2. DNA sequence chromatogram of VSX1 equivalent to codon
217 to 219. A: The reference sequence derived from control is shown.
B: Sequence derived from keratoconus patient shows homozygous
G>A nucleotide change which predicts a codon change CGC>CAC
and non-synonymous change p.R217H.
one was novel and 3 have been previously reported. Details
of these changes are given below.
Alanine182Alanine (p.A182A): In this mutation a single
nucleotide adenine (A) was replaced by guanine (G) at g.
25059546 (rs12480307); c.546; codon 182 resulted in codon
change  GCA>GCG  resulting  in  synonymous  change
p.ala182ala (p.A182A; Figure 1). This change was present as
homozygous change in 25 cases and 29 controls.
Arginine217Histidine  (p.R217H):  In  this  mutation  a
single nucleotide thymine (T) was replaced by adenine at
Figure 3. DNA sequence chromatogram of VSX1 equivalent to codon
236 to 239. A: The reference sequence derived from control is shown.
B: Sequence derived from keratoconus patient shows homozygous
T>A nucleotide change which predicts a codon change CCT>CCA
and synonymous change p.P237P.
Figure 4. DNA sequence chromatogram of VSX1 equivalent to g.
25059617 to g.25059606. A: The reference sequence derived from
control is shown. B: Sequence derived from keratoconus patient
shows  heterozygous  C>T  nucleotide  change  in  intron  2  at  g.
25059612.
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2398position  g.25059442  (rs6138482);  cDNA  position  c.650;
codon 217. This change resulted in a codon change from
CGC>CAC resulting in non-synonymous change p.arg217his
(p.R217H; Figure 2) in protein. This change was present in
only one case and was homozygous but was absent in controls.
Proline237Proline (p.P237P): In this mutation a single
nucleotide  T  was  replaced  by  A  at  position  g.25059381
(rs56157240); c.711; codon 237 resulted in a codon change
CCT>CCA  which  predicts  a  synonymous  change
p.pro237pro (p.P237P; Figure 3). This change was present in
18/50 cases (7 were homozygous and 11 were heterozygous)
being also present in 14/50 controls (9 were homozygous and
5 were heterozygous).
Cytosine  to  Thymine  in  intron  2:  A  novel  single
nucleotide change C>T at g.25059612 (Figure 4) was present
in three cases but absent in controls. Alteration is located in
2nd  intron  (IVS3–24C>T).  This  change  was  registered  at
GenBank with accession number GU471016.
PolyPhen and SIFT analysis of p.R217H showed that it
is non-pathogenic (SIFT score is >0.05 and PSIC score is
<1.5).
Improved  splice  site  predictor  tool  analysis  of  g.
25059612C>T showed that this location (g.25059612) is not
present at splice site and may not create splicing error in
VSX1  mRNA.  Conclusively,  no  pathogenic  change  was
identified in our patients.
DISCUSSION
In this study we analyzed VSX1 in 50 unrelated keratoconus
patients and controls from north India. In our patient’s, males
were affected more than females. Mutations in VSX1 gene
have been identified in association with keratoconus [12,14,
15,17,21]. Human VSX1 is a member of the CVC domain
containing  paired-like  class  of  homeoproteins.  VSX1
expression in humans was detected in embryonic craniofacial,
adult retinal, and adult corneal tissues [17,27]. The role of
VSX1 in keratoconus is still ambiguous. Previous studies have
shown that the pathogenesis of keratoconus is very complex
and several genes and gene environmental interactions play a
critical role in disease prognosis. In fact, VSX1 may have a
pleiotropic action among the tissues of the cornea leading to
keratoconus in some cases as observed for the transforming
growth  factor  (TGFBI)  gene;  which  causes  four  distinct
autosomal dominant corneal diseases [28].
In this study, four sequence variations were detected of
which 3 have been previously reported [15,20] and one was
novel. SIFT and PolyPhen analysis of p.217H showed that it
to be a non-pathogenic change. Similar findings have already
been reported in European population [15].
The VSXI variants reported in various studies include
p.L17P, p.D144E, p.N151S, p.L159M, p.G160V, p.G160D,
p.R166W, p.Q175H, p.H244R, and p.P247R [12-15,17,21].
Some of these were initially reported to be pathogenic but their
pathogenicity  could  not  be  confirmed  as  some  of  these
variants were observed in unaffected individuals also. He’on
and  associates  [14]  identified  a  compound  heterozygous
change with p.P247R and p.G160D and reported p.G160D to
be pathogenic and p.P247R to be nonpathogenic. Another
study reported p.P247R as a pathogenic change because it was
found  to  be  co-segregating  with  keratoconus.  Similarly,
p.D144E mutation was initially reported as pathogenic [20,
21,]  but  subsequent  studies  identified  its  presence  in
unaffected  individuals  and  suggested  this  to  be  a  non-
pathogenic polymorphism [29,30]. The variants p.R166W,
p.H244R, and p.L159M have been identified in keratoconus
patients but these changes did not segregate with the disease
phenotype  in  their  family  members  and  hence  were  not
considered sufficiently significant to support a pathogenic
role in keratoconus [31]. Similarly, variants p.G160V and
p.N151S have been identified in patients from the Korean
population [12] but these changes have not been reported in
other populations.
In a recent study (2009) from India, VSX1 was screened
in 66 keratoconus cases and a potentially pathogenic change
(p.Q175H) was identified in one case only [13]. In this study, 
the second from India, no pathogenic change  was indentified
in VSX1. Similar results have been published recently [29,
32,33]. So lack of possibly pathogenic changes in VSX1 gene
in keratoconus patients suggests that mutations of VSX1 could
only be responsible for a very small fraction of all observed
cases and need to be investigated in different populations. This
also suggests that other genetic loci like 13q32 as suggested
by Gajecka et al. [34] may be involved in the pathogenesis of
keratoconus.
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